Paper39337494
Hydrogen Sulfide-Releasing Carbonic Anhydrase Inhibitors Effectively Suppress Cancer Cell Growth.
Bonardi A and 6 others. Int J Mol Sci, 2024. Cited by 11 papers, by iCite.
Cite this record
ConductScience Library. Hydrogen Sulfide-Releasing Carbonic Anhydrase Inhibitors Effectively Suppress Cancer Cell Growth. Papers, record 39337494. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39337494
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Hydrogen Sulfide-Releasing Carbonic Anhydrase Inhibitors Effectively Suppress Cancer Cell Growth.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Hydrogen Sulfide | Major topic |
| Carbonic Anhydrase Inhibitors | Major topic |
| Cell Proliferation | Major topic |
| Apoptosis | Major topic |
| Humans | |
| Antineoplastic Agents | |
| Cell Line, Tumor | |
| Carbonic Anhydrases | |
| Cell Cycle | |
| HCT116 Cells | |
| Neoplasms | |
| A549 Cells |
Source PubMed
References76
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 10353251 | The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. | Nature | 1999 | https://conductscience.org/library/papers/10353251 | PubMed |
| 2 | 22451434 | Lactate flux in astrocytes is enhanced by a non-catalytic action of carbonic anhydrase II. | J Physiol | 2012 | https://conductscience.org/library/papers/22451434 | PubMed |
| 3 | 35506234 | Targeting carbonic anhydrase IX and XII isoforms with small molecule inhibitors and monoclonal antibodies. | J Enzyme Inhib Med Chem | 2022 | https://conductscience.org/library/papers/35506234 | PubMed |
| 4 | 26778478 | The Warburg Effect: How Does it Benefit Cancer Cells? | Trends Biochem Sci | 2016 | https://conductscience.org/library/papers/26778478 | PubMed |
| 5 | 12671706 | Carbonic anhydrase XII is a marker of good prognosis in invasive breast carcinoma. | Br J Cancer | 2003 | https://conductscience.org/library/papers/12671706 | PubMed |
| 6 | 28874874 | 3-Mercaptopyruvate sulfurtransferase produces potential redox regulators cysteine- and glutathione-persulfide (Cys-SSH and GSSH) together with signaling molecules H2S2, H2S3 and H2S. | Sci Rep | 2017 | https://conductscience.org/library/papers/28874874 | PubMed |
| 7 | 30445264 | Enhancement of the tail hydrophobic interactions within the carbonic anhydrase IX active site via structural extension: Design and synthesis of novel N-substituted isatins-SLC-0111 hybrids as carbonic anhydrase inhibitors and antitumor agents. | Eur J Med Chem | 2019 | https://conductscience.org/library/papers/30445264 | PubMed |
| 8 | 28978633 | International Union of Basic and Clinical Pharmacology. CII: Pharmacological Modulation of H2S Levels: H2S Donors and H2S Biosynthesis Inhibitors. | Pharmacol Rev | 2017 | https://conductscience.org/library/papers/28978633 | PubMed |
| 9 | 30822194 | The Warburg effect: essential part of metabolic reprogramming and central contributor to cancer progression. | Int J Radiat Biol | 2019 | https://conductscience.org/library/papers/30822194 | PubMed |
| 10 | 11069930 | Interstitial carbonic anhydrase (CA) activity in brain is attributable to membrane-bound CA type IV. | J Neurosci | 2000 | https://conductscience.org/library/papers/11069930 | PubMed |
| 11 | 36630819 | Implications of hydrogen sulfide in colorectal cancer: Mechanistic insights and diagnostic and therapeutic strategies. | Redox Biol | 2023 | https://conductscience.org/library/papers/36630819 | PubMed |
| 12 | 36901756 | Carbonic Anhydrase IX in Tumor Tissue and Plasma of Breast Cancer Patients: Reliable Biomarker of Hypoxia and Prognosis. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/36901756 | PubMed |
| 13 | 16265666 | Functional demonstration of surface carbonic anhydrase IV activity on rat astrocytes. | Glia | 2006 | https://conductscience.org/library/papers/16265666 | PubMed |
| 14 | 21361354 | Ureido-substituted benzenesulfonamides potently inhibit carbonic anhydrase IX and show antimetastatic activity in a model of breast cancer metastasis. | J Med Chem | 2011 | https://conductscience.org/library/papers/21361354 | PubMed |
| 15 | 24635322 | Anti-inflammatory and cytoprotective actions of hydrogen sulfide: translation to therapeutics. | Antioxid Redox Signal | 2015 | https://conductscience.org/library/papers/24635322 | PubMed |
| 16 | 35432450 | Therapeutic Targeting Hypoxia-Inducible Factor (HIF-1) in Cancer: Cutting Gordian Knot of Cancer Cell Metabolism. | Front Genet | 2022 | https://conductscience.org/library/papers/35432450 | PubMed |
| 17 | 15516961 | Why do cancers have high aerobic glycolysis? | Nat Rev Cancer | 2004 | https://conductscience.org/library/papers/15516961 | PubMed |
| 18 | 12560438 | Carbonic anhydrase IX expression, a novel surrogate marker of tumor hypoxia, is associated with a poor prognosis in non-small-cell lung cancer. | J Clin Oncol | 2003 | https://conductscience.org/library/papers/12560438 | PubMed |
| 19 | 31076951 | The role of carbonic anhydrase IX in cancer development: links to hypoxia, acidosis, and beyond. | Cancer Metastasis Rev | 2019 | https://conductscience.org/library/papers/31076951 | PubMed |
| 20 | 29100428 | Lactate stimulates CA IX expression in normoxic cancer cells. | Oncotarget | 2017 | https://conductscience.org/library/papers/29100428 | PubMed |
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 11 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42936388 | Nutritional regulation of the tumor immune microenvironment: metabolic mechanisms, immunotherapy response, and nursing implications. | Front Immunol | 2026 | https://conductscience.org/library/papers/42936388 | PubMed |
| 42493680 | Compartmental pH regulation in cancer and antitumor immunity: therapeutic opportunities and challenges. | Apoptosis | 2026 | https://conductscience.org/library/papers/42493680 | PubMed |
| 42062767 | Future Directions in Biotechnological and Pharmacological Applications of CAIs. | Subcell Biochem | 2026 | https://conductscience.org/library/papers/42062767 | PubMed |
| 42062761 | Computational Approaches and Structure-Based Drug Design of CAIs. | Subcell Biochem | 2026 | https://conductscience.org/library/papers/42062761 | PubMed |
| 41754830 | Synthesis of Hydrazidoureidobenzensulfonamides Incorporating a Nicotinoyl Tail and Their Carbonic Anhydrase I, II, IX and XII Inhibitory Activity. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/41754830 | PubMed |
| 41694345 | Gasotransmitters bridging tumor biology and immunity: from pathophysiological insights to therapeutic potential. | Front Immunol | 2026 | https://conductscience.org/library/papers/41694345 | PubMed |
| 41226466 | 4-Methylumbelliferone Modulates CAIX to Mitigate Hypoxia-Driven Dysregulation and Enhance PD-1 Immunotherapy in Lung Cancer. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41226466 | PubMed |
| 39766602 | Bisindole Compounds-Synthesis and Medicinal Properties. | Antibiotics (Basel) | 2024 | https://conductscience.org/library/papers/39766602 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39337494
GET https://conductscience.org/api/papers/v1/39337494/references?page=2